504 related articles for article (PubMed ID: 34647145)
1. Prediction of insufficient hepatic enhancement during the Hepatobiliary phase of Gd-EOB DTPA-enhanced MRI using machine learning classifier and feature selection algorithms.
Ko JS; Byun J; Park S; Woo JY
Abdom Radiol (NY); 2022 Jan; 47(1):161-173. PubMed ID: 34647145
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a predictor of insufficient enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging.
Cui E; Long W; Luo L; Hu M; Huang L; Chen X
Acta Radiol; 2017 Oct; 58(10):1174-1181. PubMed ID: 28090793
[TBL] [Abstract][Full Text] [Related]
3. Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla.
Verloh N; Haimerl M; Zeman F; Schlabeck M; Barreiros A; Loss M; Schreyer AG; Stroszczynski C; Fellner C; Wiggermann P
Eur Radiol; 2014 May; 24(5):1013-9. PubMed ID: 24531844
[TBL] [Abstract][Full Text] [Related]
4. Clinical factors predictive of insufficient liver enhancement on the hepatocyte-phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging in patients with liver cirrhosis.
Kim HY; Choi JY; Park CH; Song MJ; Song DS; Kim CW; Bae SH; Yoon SK; Lee YJ; Rha SE
J Gastroenterol; 2013 Oct; 48(10):1180-7. PubMed ID: 23354621
[TBL] [Abstract][Full Text] [Related]
5. Assessing liver function: diagnostic efficacy of parenchymal enhancement and liver volume ratio of Gd-EOB-DTPA-enhanced MRI study during interstitial and hepatobiliary phase.
Ippolito D; Pecorelli A; Famularo S; Bernasconi D; Orsini EB; Giani A; Romano F; Talei Franzesi C; Sironi S
Abdom Radiol (NY); 2019 Apr; 44(4):1340-1349. PubMed ID: 30411177
[TBL] [Abstract][Full Text] [Related]
6. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.
Tateyama A; Fukukura Y; Takumi K; Shindo T; Kumagae Y; Kamimura K; Nakajo M
World J Gastroenterol; 2012 Nov; 18(43):6269-76. PubMed ID: 23180948
[TBL] [Abstract][Full Text] [Related]
7. Liver function correlates with liver-to-portal vein contrast ratio during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MR at 3 Tesla.
Zhang W; Wang X; Miao Y; Hu C; Zhao W
Abdom Radiol (NY); 2018 Sep; 43(9):2262-2269. PubMed ID: 29476347
[TBL] [Abstract][Full Text] [Related]
8. Hepatic enhancement of Gd-EOB-DTPA-enhanced 3 Tesla MR imaging: Assessing severity of liver cirrhosis.
Lee S; Choi D; Jeong WK
J Magn Reson Imaging; 2016 Nov; 44(5):1339-1345. PubMed ID: 27197633
[TBL] [Abstract][Full Text] [Related]
9. Gd-EOB-DTPA enhanced MRI based radiomics combined with clinical variables in stratifying hepatic functional reserve in HBV infected patients.
Hu J; Wang X; Prince M; Wang F; Sun J; Yang X; Wang W; Ye J; Chen L; Luo X
Abdom Radiol (NY); 2024 Apr; 49(4):1051-1062. PubMed ID: 38294541
[TBL] [Abstract][Full Text] [Related]
10. Gd-EOB-DTPA enhanced MRI of the liver: correlation of relative hepatic enhancement, relative renal enhancement, and liver to kidneys enhancement ratio with serum hepatic enzyme levels and eGFR.
Talakic E; Steiner J; Kalmar P; Lutfi A; Quehenberger F; Reiter U; Fuchsjäger M; Schöllnast H
Eur J Radiol; 2014 Apr; 83(4):607-11. PubMed ID: 24380639
[TBL] [Abstract][Full Text] [Related]
11. Improved parenchymal liver enhancement with extended delay on Gd-EOB-DTPA-enhanced MRI in patients with parenchymal liver disease: associated clinical and imaging factors.
Esterson YB; Flusberg M; Oh S; Mazzariol F; Rozenblit AM; Chernyak V
Clin Radiol; 2015 Jul; 70(7):723-9. PubMed ID: 25921617
[TBL] [Abstract][Full Text] [Related]
12. T
Yang L; Ding Y; Rao S; Chen C; Zeng M
J Magn Reson Imaging; 2021 Mar; 53(3):896-902. PubMed ID: 32979019
[TBL] [Abstract][Full Text] [Related]
13. Machine learning-based radiomics analysis of preoperative functional liver reserve with MRI and CT image.
Zhu L; Wang F; Chen X; Dong Q; Xia N; Chen J; Li Z; Zhu C
BMC Med Imaging; 2023 Jul; 23(1):94. PubMed ID: 37460944
[TBL] [Abstract][Full Text] [Related]
14. [The predictive value of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid enhanced MRI imaging features combined with quantitative parameters for the pathologic grading of hepatocellular carcinoma].
Hu MJ; Yu YX; Fan YF; Jiang YM; Hu S; Wang XM; Hu CH
Zhonghua Yi Xue Za Zhi; 2020 May; 100(17):1299-1304. PubMed ID: 32375436
[No Abstract] [Full Text] [Related]
15. Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid.
Lin CY; Chang WC; Chou CT; Chen RC
J Chin Med Assoc; 2015 Nov; 78(11):666-72. PubMed ID: 26341453
[TBL] [Abstract][Full Text] [Related]
16. Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI.
Feng ST; Jia Y; Liao B; Huang B; Zhou Q; Li X; Wei K; Chen L; Li B; Wang W; Chen S; He X; Wang H; Peng S; Chen ZB; Tang M; Chen Z; Hou Y; Peng Z; Kuang M
Eur Radiol; 2019 Sep; 29(9):4648-4659. PubMed ID: 30689032
[TBL] [Abstract][Full Text] [Related]
17. Predicting Patients With Insufficient Liver Enhancement in the Hepatobiliary Phase Before the Injection of Gadoxetic Acid: A Practical Approach Using the Bayesian Method.
Mori Y; Motosugi U; Shimizu T; Ichikawa S; Kromrey ML; Onishi H
J Magn Reson Imaging; 2020 Jan; 51(1):62-69. PubMed ID: 31016840
[TBL] [Abstract][Full Text] [Related]
18. Optimization of hepatobiliary phase delay time of Gd-EOB-DTPA-enhanced magnetic resonance imaging for identification of hepatocellular carcinoma in patients with cirrhosis of different degrees of severity.
Wu JW; Yu YC; Qu XL; Zhang Y; Gao H
World J Gastroenterol; 2018 Jan; 24(3):415-423. PubMed ID: 29391764
[TBL] [Abstract][Full Text] [Related]
19. Measuring hepatic functional reserve using T1 mapping of Gd-EOB-DTPA enhanced 3T MR imaging: A preliminary study comparing with
Nakagawa M; Namimoto T; Shimizu K; Morita K; Sakamoto F; Oda S; Nakaura T; Utsunomiya D; Shiraishi S; Yamashita Y
Eur J Radiol; 2017 Jul; 92():116-123. PubMed ID: 28624009
[TBL] [Abstract][Full Text] [Related]
20. Prediction of acute kidney injury in patients with liver cirrhosis using machine learning models: evidence from the MIMIC-III and MIMIC-IV.
Tian J; Cui R; Song H; Zhao Y; Zhou T
Int Urol Nephrol; 2024 Jan; 56(1):237-247. PubMed ID: 37256426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
